|
⚲
|
| Keyboard |
| Symmetry Investments LP
✚
|
|
|---|---|
| CRD # | 171484 |
| SEC # | 802-80046 |
| CIK # | 0001861029, 0001691919, 0002004843, 0002111130, 0002055506 |
| AUM | |
| Employees | |
| Phone | 402070723100 |
| Address | 10 Le Capelain House, Castle Quay St Helier, Jersey |
| Source | [IAPD] [EDGAR] [Website] [Twitter] [LinkedIn] |
| Total AUM ($) |
|---|
| In the News | |
|---|---|
| Fri, 17 Jul 2026 | Symmetry Investments receives regulatory approval to operate in Dubai — Crypto Briefing |
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Apple Inc | 0.0 | ||
| Nvidia Corp | 0.0 | ||
| Cisco Systems Inc | 0.0 | ||
| Amazon Com Inc | 0.0 | ||
| Tempus AI Inc | 0.0 | ||
| Tesla Motors Inc | 0.0 | ||
| Microsoft Corp | 0.0 | ||
| Holdings by Sector ($B) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | Symmetry Adaptive Fund Limited | [2021-03-26] | 439.3 M | 79.55 B |
| Filed 2025-08-08 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Symmetry Cash Management Master Limited | 2020-03-30 | 1.5 M | |
| HF | Symmetry Master Fund Limited | [2014-06-30] | 387.3 M | 315.40 B |
| Filed 2025-10-15 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 0 | 0.0 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 0 | 0.0 |
| By Discretionary | ||
| Discretionary | 0 | 0.0 |
| Non-Discretionary | 0 | 0.0 |
| Total | 0 | 0.0 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 0.0 | |
| Total | 0 | 0.0 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| William Jones | Director | 165 | 37 | |
| Todd Groome | Director | 12 | 7 | |
| Timothy Sweeting | Director | 28 | 6 | |
| Michael Robinson | Director | 49 | 5 | |
| Michael Edleson | Director | 10 | 4 | |
| Symmetry Investments US LLC | Promoter | 4 | 2 | |
| Symmetry Investments LP | Promoter | 4 | 2 | |
| Symmetry Investments Singapore Private Limited | Promoter | 4 | 2 | |
| Symmetry Investments UK Llp | Promoter | 4 | 2 | |
| Symmetry Investments Jersey Limited | Promoter | 4 | 2 | |
| Symmetry Investments Cayman Limited | Promoter | 4 | 2 | |
| Symmetry Investments Hong Kong Limited | Promoter | 4 | 2 | |
| Symmetry Investments Hong Kong Ltd | Promoter | 3 | 2 | |
| Symmetry Investments Jersey Ltd | Promoter | 1 | 1 | |
| Symmetry Adaptive Fund GP Limited | Executive Officer | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001691919] | |
| 3 | [0001861029] | |
| 4 | [0001861029] | |
| 13F-HR | [0002004843] | |
| 13F-NT | [0002055506] | |
| D | [0002111130] |
| Firm Profile (Form ADV) | |
|---|---|
| Fund Types | Hedge Fund |
| LEI | 549300YN6M3DGUTFBP16 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
PMV Pharmaceuticals Inc PMVP
Common Stock
|
2021-06-14 | Sell | 4,699 | $34.11 | 160,283 |
|
PMV Pharmaceuticals Inc PMVP
Common Stock
|
2021-06-14 | Sell | 1,260 | $34.11 | 42,979 |
|
PMV Pharmaceuticals Inc PMVP
Common Stock
|
2021-06-14 | Sell | 24,726 | $34.11 | 843,404 |
|
PMV Pharmaceuticals Inc PMVP
Common Stock
|
2021-06-14 | Sell | 7,141 | $34.11 | 243,580 |
|
PMV Pharmaceuticals Inc PMVP
Common Stock
|
2021-06-14 | Sell | 6,593 | $34.11 | 224,887 |
|
PMV Pharmaceuticals Inc PMVP
Common Stock
|
2021-06-11 | Sell | 3,262 | $33.80 | 110,256 |
|
PMV Pharmaceuticals Inc PMVP
Common Stock
|
2021-06-11 | Sell | 621 | $33.80 | 20,990 |
|
PMV Pharmaceuticals Inc PMVP
Common Stock
|
2021-06-11 | Sell | 12,237 | $33.80 | 413,611 |
|
PMV Pharmaceuticals Inc PMVP
Common Stock
|
2021-06-11 | Sell | 3,533 | $33.80 | 119,415 |
|
PMV Pharmaceuticals Inc PMVP
Common Stock
|
2021-06-11 | Sell | 2,324 | $33.80 | 78,551 |
|
PMV Pharmaceuticals Inc PMVP
Common Stock
|
2021-06-10 | Sell | 2,183 | $32.68 | 71,340 |
|
PMV Pharmaceuticals Inc PMVP
Common Stock
|
2021-06-10 | Sell | 585 | $32.68 | 19,118 |
|
PMV Pharmaceuticals Inc PMVP
Common Stock
|
2021-06-10 | Sell | 3,063 | $32.68 | 100,099 |
|
PMV Pharmaceuticals Inc PMVP
Common Stock
|
2021-06-10 | Sell | 3,317 | $32.68 | 108,400 |
|
PMV Pharmaceuticals Inc PMVP
Common Stock
|
2021-06-10 | Sell | 11,485 | $32.68 | 375,330 |
|
PMV Pharmaceuticals Inc PMVP
Common Stock
|
2021-06-09 | Sell | 4,192 | $33.64 | 141,019 |
|
PMV Pharmaceuticals Inc PMVP
Common Stock
|
2021-06-09 | Sell | 22,070 | $33.64 | 742,435 |
|
PMV Pharmaceuticals Inc PMVP
Common Stock
|
2021-06-09 | Sell | 6,372 | $33.64 | 214,354 |
|
PMV Pharmaceuticals Inc PMVP
Common Stock
|
2021-06-09 | Sell | 5,883 | $33.64 | 197,904 |
|
PMV Pharmaceuticals Inc PMVP
Common Stock
|
2021-06-09 | Sell | 1,121 | $33.64 | 37,710 |
| showing 20 of 30 most recent transactions | |||||